Circulating tumour DNA in gastrointestinal cancer in clinical practice: Just a dream or maybe not?

The evaluation of circulating tumor DNA (ctDNA) is increasingly integrated into the management of diagnosis and treatment of gastrointestinal cancer as it represents an innovative and minimally invasive biomarker that could allow us to reach clinical needs not met yet in randomized clinical trials....

Descripción completa

Detalles Bibliográficos
Autores principales: Pretta, Andrea, Lai, Eleonora, Donisi, Clelia, Spanu, Dario, Ziranu, Pina, Pusceddu, Valeria, Puzzoni, Marco, Massa, Elena, Scartozzi, Mario
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9813836/
https://www.ncbi.nlm.nih.gov/pubmed/36618080
http://dx.doi.org/10.5306/wjco.v13.i12.980

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9813836/
https://www.ncbi.nlm.nih.gov/pubmed/36618080
http://dx.doi.org/10.5306/wjco.v13.i12.980

Ejemplares similares